<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Magri F</submitter><funding>Ministero della Salute</funding><pagination>9817</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9456520</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(17)</volume><pubmed_abstract>Limb-girdle muscular dystrophies (LGMD) are clinically and genetically heterogenous presentations displaying predominantly proximal muscle weakness due to the loss of skeletal muscle fibers. Beta-sarcoglycanopathy (LGMDR4) results from biallelic molecular defects in &lt;i>SGCB&lt;/i> and features pediatric onset with limb-girdle involvement, often complicated by respiratory and heart dysfunction. Here we describe a patient who presented at the age of 12 years reporting high creatine kinase levels and onset of cramps after strenuous exercise. Instrumental investigations, including a muscle biopsy, pointed towards a diagnosis of beta-sarcoglycanopathy. NGS panel sequencing identified two variants in the &lt;i>SGCB&lt;/i> gene, one of which (c.243+1548T&amp;gt;C) was found to promote the inclusion of a pseud</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the &lt;i>SGCB&lt;/i> Gene.</pubmed_title><pmcid>PMC9456520</pmcid><funding_grant_id>Current Research</funding_grant_id><pubmed_authors>Fortunato F</pubmed_authors><pubmed_authors>Maggi L</pubmed_authors><pubmed_authors>Salani S</pubmed_authors><pubmed_authors>Gerevini S</pubmed_authors><pubmed_authors>Zanotti S</pubmed_authors><pubmed_authors>Corti S</pubmed_authors><pubmed_authors>Sciacco M</pubmed_authors><pubmed_authors>Magri F</pubmed_authors><pubmed_authors>Bresolin N</pubmed_authors><pubmed_authors>Ciscato P</pubmed_authors><pubmed_authors>Comi GP</pubmed_authors><pubmed_authors>Ronchi D</pubmed_authors><pubmed_authors>Moggio M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the &lt;i>SGCB&lt;/i> Gene.</name><description>Limb-girdle muscular dystrophies (LGMD) are clinically and genetically heterogenous presentations displaying predominantly proximal muscle weakness due to the loss of skeletal muscle fibers. Beta-sarcoglycanopathy (LGMDR4) results from biallelic molecular defects in &lt;i>SGCB&lt;/i> and features pediatric onset with limb-girdle involvement, often complicated by respiratory and heart dysfunction. Here we describe a patient who presented at the age of 12 years reporting high creatine kinase levels and onset of cramps after strenuous exercise. Instrumental investigations, including a muscle biopsy, pointed towards a diagnosis of beta-sarcoglycanopathy. NGS panel sequencing identified two variants in the &lt;i>SGCB&lt;/i> gene, one of which (c.243+1548T&amp;gt;C) was found to promote the inclusion of a pseud</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-05-29T19:35:54.531Z</modification><creation>2024-11-06T04:01:33.617Z</creation></dates><accession>S-EPMC9456520</accession><cross_references><pubmed>36077211</pubmed><doi>10.3390/ijms23179817</doi></cross_references></HashMap>